Lichtenberg, Frank

Lichtenberg, Frank R. 1984. The Relationship between Federal Contract R D and Company RScD. American Economic Review 74(2) 73-78. 

Lichtenberg, Frank R. 1986. Energy Prices and Induced Innovation. Research Policy 15 67-75. 

Lichtenberg, Frank R. 1987. Changing Market Opportunities and the Structure of RScD Investment The Case ofEnergy. Energy Economics 9(3) 154-158. 

Lichtenberg, Frank R. 1988. The Private RScD Investment Response to Federal Design and Technical Competitions. American Economic Review 78(3) 550-559. 

Lichtenberg, Frank R. 1996. The Effect of Pharmaceutical UtUization and Innovation on Hospitalization and Mortality. National Bureau of Economic Research Working Paper 5418. 

Lichtenberg, Frank R. 2003c. The Benefits to Society of New Drugs A Survey of the Econometric Evidence. Proceedings of the Federal Reserve Bank of Dallas (September) 43-59. 

Lichtenberg, Frank R. 2004a. Public Policy and Innovation in the U.S. Pharmaceutical Industry, in Public Policy and the Economics of Entrepreneurship, ed. by Douglas Holtz-Eakin and Harvey S. Rosen, 83-113. Cambridge, MA MIT Press. 

Lichtenberg, Frank R. 2004b. Sources of U.S. Longevity Increase, 1960-2001. Quarterly Review of Economics and Finance 44(3) 369-389. 

Lichtenberg, Frank R. 2005a. Pharmaceutical Innovation and the Burden of Disease in Developed and Developing Countries. Journal of Medicine and Philosophy 30(6) 663-690. 

Lichtenberg, Frank R. 2005b. The Impact of New Drug Launches on Longevity Evidence from Longitudinal Disease-level Data from 52 Countries, 1982-2001. International Journal of Health Care Finance and Economics 5(1) 47-73. 

Lichtenberg, Frank R., Are the Benefits of Newer Drugs Worth Their Cost Evidence from the 1996 MEPS, Health Affairs, September-October 2001. 

Lichtenberg, Frank R., The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output, March 2002. 

Lichtenberg, Frank, and Donald Siegel (1990) The Effects of Leveraged Buyouts on Productivity and Related Aspects of Firm Behavior, Journal of Financial Economics, v.27, p. 165-94. 

Lichtenberg, Frank, 1992, Corporate Takeovers and Productivity, Cambridge MIT Press. 

Lichtenberg, Frank, Bruno van Pottelsberghe de la Potterie, 1996, The Channels of International R D Spillovers, Paper prepared for the OECD-Conference on the NEW Indicators for the Knowledge based Economy, 19 -21 June, Paris. 

To Frank R. Lichtenberg, a professor of economics and finance at Columbia University s Graduate School of Business in New York who specializes in the pharmaceutical industry, the outpouring against the big drug giants wasn t all that surprising. If their access to pharmaceutical products is limited by price or other reasons, people get upset, he points out. That s testimony to the pharmaceutical companies activity and their contribution to society. ... 

---